Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: A systematic review and meta-analysis

Obstetrics and Gynecology

Volumn 113, Issue 5, 2009, Pages 1104-1116

  Kaunitz, Andrew M ^a   Meredith, Susanna ^b   Inki, Pirjo ^b   Kubba, Ali ^b   Sanchez Ramos, Luis ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ACNE; ANXIETY; BLOATING; BREAST TENDERNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG INDUCED HEADACHE; DYSMENORRHEA; EDEMA; ENDOMETRITIS; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; HAIR LOSS; HEAVY MENSTRUAL BLEEDING; HEMATOMETRA; HUMAN; HUMAN TISSUE; HYPERTENSION; HYSTEROSCOPY; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LEG PAIN; LIBIDO DISORDER; LOWER ABDOMINAL PAIN; MASTALGIA; MENORRHAGIA; MENSTRUATION DISORDER; META ANALYSIS; METRORRHAGIA; MOOD CHANGE; NAUSEA; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SPOTTING; SYSTEMATIC REVIEW; TREATMENT FAILURE; VAGINA DISCHARGE; WEIGHT GAIN; FEMALE;

CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIAL ABLATION TECHNIQUES; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; MENORRHAGIA;

EID: 66149135261     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a1d3ce     Document Type: Review

References (53)

1. McGurgan P, O'Donovan P. Second-generation endometrial ablation: an overview. Best Pract Res Clin Obstet Gynaecol 2007;21:931-45.
2. Zarek S, Sharp HT. Global endometrial ablation devices. Clin Obstet Gynecol 2008;51:167-75.
3. McCausland AM, McCausland VM. Long-term complications of endometrial ablation: cause, diagnosis, treatment, and prevention. J Minim Invasive Gynecol 2007;14:399-406.
4. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;CD000329.
5. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2006;(2):CD003855.
6. National Institute for Health and Clinical Excellence (NICE). Heavy menstrual bleeding, 2007. Available at: http://www. nice.org.uk/guidance/CG44. Retrieved March 17, 2008.
7. Lahteenmaki P, Haukkamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998;316:1122-6.
8. Nagrani R, Bowen-Simpkins P, Barrington JW. Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia? BJOG 2002;109:345-7.
9. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel- releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-63.
10. Barrington JW, Arunkalaivanan AS, Abdel-Fattah M. Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol 2003;108:72-4.
11. Romer T. Prospective comparison study of levonorgestrel IUD versus Roller-Ball endometrial ablation in the management of refractory recurrent hypermenorrhea. Eur J Obstet Gynecol Reprod Biol 2000;90:27-9.
12. Soysal S, Soysal ME. The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial. Gynecol Obstet Invest 2005;59:29-35.
13. Malak K, Shawki O. Management of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Gynecol Surg 2006;3:275-80.
14. Gupta B, Mittal S, Misra R, Deka D, Dadhwal V. Levonorgestrel- releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding. Int J Gynaecol Obstet 2006;95:261-6.
15. Shaw RW, Symonds IM, Tamizian O, Chaplain J, Mukhopadhyay S. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Aust N Z J Obstet Gynaecol 2007;47: 335-40.
16. Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006;113:257-63.
17. Soysal M, Soysal S, Ozer S. A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralbl Gynakol 2002;124: 213-9.
18. Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90: 257-63.
19. Tam WH, Yuen PM, Shan Ng DP, Leung PL, Lok IH, Rogers MS. Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomized study. Gynecol Obstet Invest 2006;62:84-8.
20. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;(2):CD001501.
21. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354:1896-900.
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
23. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995;85:977-82.
24. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9.
25. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. Br J Obstet Gynaecol 2000;107:320-2.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
27. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
29. Breslow NE, Day NE. Statistical methods in cancer research. Volume I: The analysis of case-control studies. IARC Sci Publ 1980;5-338.
30. Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004;104:1314-21.
31. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol 2005;5:19.
32. Mirena physician information. Bayer Healthcare. Available at: http://www.mirena-us.com/index.jsp. Retrieved November 8, 2008.
33. Campbell SJ, Cropsey KL, Matthews CA. Intrauterine device use in a high-risk population: experience from an urban university clinic. Am J Obstet Gynecol 2007;197:193:e1-6; discussion e6-7.
34. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49: 56-72.
35. Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study: Minimally Invasive Surgical Techniques-Laser, EndoThermal or Endorescetion. Br J Obstet Gynaecol 1997;104:1351-9.
36. Gurtcheff SE, Sharp HT. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 2003;102:1278-82.
37. Della Badia C, Nyirjesy P, Atogho A. Endometrial ablation devices: review of a manufacturer and user facility device experience database. J Minim Invasive Gynecol 2007;14: 436-41.
38. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994; 61:70-7.
39. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system; a follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-21.
40. Halmesmaki K, Hurskainen R, Tiitinen A, Teperi J, Grenman S, Kivela A, et al. A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms. Hum Reprod 2004;19:378-82.
41. Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 2007;75:S161-6.
42. Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen A-L, et al. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Am J Obstet Gynecol 2008;199:529: e1-10.
43. Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No. 73. American College of Obstetricians and Gynecologists. Obstet Gynecol 2006;107:1453-72.
44. Fraser IS. The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease. Contraception 2007;75:S112-7.
45. MacLean-Fraser E, Penava D, Vilos GA. Perioperative complication rates of primary and repeat hysteroscopic endometrial ablations. J Am Assoc Gynecol Laparosc 2002;9:175-7.
46. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 1992;46:575-84.
47. Belhadj H, Sivin I, Diaz S, Pavez M, Tejada AS, Brache V, et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 1986; 34:261-7.
48. Nilsson CG. Fertility after discontinuation of levonorgestrelreleasing intrauterine devices. Contraception 1982;25:273-8.
49. Sivin I, Stern J, Diaz S, Pavez M, Alvarez F, Brache V, et al. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol 1992;166:1208-13.
50. Cook JR, Seman EI. Pregnancy following endometrial ablation: case history and literature review. Obstet Gynecol Surv 2003;58:551-6.
51. Gervaise A, de Tayrac R, Fernandez H. Contraceptive information after endometrial ablation. Fertil Steril 2005;84: 1746-7.
52. Mukul LV, Linn JG. Pregnancy complicated by uterine synechiae after endometrial ablation. Obstet Gynecol 2005;105: 1179-82.
53. Lo JS, Pickersgill A. Pregnancy after endometrial ablation: English literature review and case report. J Minim Invasive Gynecol 2006;13:88-91.